ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
Objective: The aim of the study; To determine the frequency, etiological factors, treatment, long-term follow-up and recurrence rates of thrombosis in children. Methodology: Children with thrombosis in Ankara City Hospital between December 2018 and August 2021 were included. Patients were called or...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-11-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137921012153 |
| _version_ | 1818569364960444416 |
|---|---|
| author | Yunus Murat Akcabelen Volkan Köse Dilek Gürlek Gökçebay Turan Bayhan Namık Yaşar Özbek Neşe Yaralı |
| author_facet | Yunus Murat Akcabelen Volkan Köse Dilek Gürlek Gökçebay Turan Bayhan Namık Yaşar Özbek Neşe Yaralı |
| author_sort | Yunus Murat Akcabelen |
| collection | DOAJ |
| description | Objective: The aim of the study; To determine the frequency, etiological factors, treatment, long-term follow-up and recurrence rates of thrombosis in children. Methodology: Children with thrombosis in Ankara City Hospital between December 2018 and August 2021 were included. Patients were called or examined at 6–12-month intervals. Results: A total of 328 patients with a mean age of 6.9 were included.Catheter-related thrombosis was present in 52.7%.There were 14% arterial thrombosis and 59% venous thrombosis.Intracardiac thrombosis 16.2%, pulmonar thrombosis 2.4%, serebral thromboembolism %20 were detected.In the treatment, subcutaneous ondansetron (78.6%) was used mostly, but intravenous ondansetron was given in 6 patients and TPA was given 20 patients.In a mean follow-up of 15.8 months, 5 (1.5%) patients died due to thrombosis. Conclusion: Determining the etiological factors of patients with recurrence thrombosis is important for the duration of treatment in the follow-up. |
| first_indexed | 2024-12-14T06:47:10Z |
| format | Article |
| id | doaj.art-69644907b6294b168925d998716370b3 |
| institution | Directory Open Access Journal |
| issn | 2531-1379 |
| language | English |
| last_indexed | 2024-12-14T06:47:10Z |
| publishDate | 2021-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Hematology, Transfusion and Cell Therapy |
| spelling | doaj.art-69644907b6294b168925d998716370b32022-12-21T23:13:00ZengElsevierHematology, Transfusion and Cell Therapy2531-13792021-11-0143S54ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIALYunus Murat Akcabelen0Volkan Köse1Dilek Gürlek Gökçebay2Turan Bayhan3Namık Yaşar Özbek4Neşe Yaralı5University of Health Sciences, Ankara City Hospital, Pediatric Hematology and OncologyUniversity of Health Sciences, Ankara City Hospital, Pediatric Hematology and OncologyUniversity of Health Sciences, Ankara City Hospital, Pediatric Hematology and OncologyUniversity of Health Sciences, Ankara City Hospital, Pediatric Hematology and OncologyUniversity of Health Sciences, Ankara City Hospital, Pediatric Hematology and OncologyAnkara Yıldırım Beyazıt University Ankara City Hospital, Pediatric Hematology and OncologyObjective: The aim of the study; To determine the frequency, etiological factors, treatment, long-term follow-up and recurrence rates of thrombosis in children. Methodology: Children with thrombosis in Ankara City Hospital between December 2018 and August 2021 were included. Patients were called or examined at 6–12-month intervals. Results: A total of 328 patients with a mean age of 6.9 were included.Catheter-related thrombosis was present in 52.7%.There were 14% arterial thrombosis and 59% venous thrombosis.Intracardiac thrombosis 16.2%, pulmonar thrombosis 2.4%, serebral thromboembolism %20 were detected.In the treatment, subcutaneous ondansetron (78.6%) was used mostly, but intravenous ondansetron was given in 6 patients and TPA was given 20 patients.In a mean follow-up of 15.8 months, 5 (1.5%) patients died due to thrombosis. Conclusion: Determining the etiological factors of patients with recurrence thrombosis is important for the duration of treatment in the follow-up.http://www.sciencedirect.com/science/article/pii/S2531137921012153 |
| spellingShingle | Yunus Murat Akcabelen Volkan Köse Dilek Gürlek Gökçebay Turan Bayhan Namık Yaşar Özbek Neşe Yaralı ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL Hematology, Transfusion and Cell Therapy |
| title | ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL |
| title_full | ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL |
| title_fullStr | ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL |
| title_full_unstemmed | ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL |
| title_short | ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL |
| title_sort | etiology treatment and follow up of thrombosis in children one center prospective trial |
| url | http://www.sciencedirect.com/science/article/pii/S2531137921012153 |
| work_keys_str_mv | AT yunusmuratakcabelen etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT volkankose etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT dilekgurlekgokcebay etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT turanbayhan etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT namıkyasarozbek etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT neseyaralı etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial |